Powered by: Motilal Oswal
01-01-1970 12:00 AM | Source: Angel Broking Ltd
Indoco Remedies - 4QFY21 By Mr. Yash Gupta, Angel Broking Ltd
News By Tags | #5948 #607 #2840 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Below are Quote on Indoco Remedies - 4QFY21 by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd   

Indoco Remedies limited reported total revenue from operations at ₹305.1 crores up by 12% YoY from ₹272 crores in Q4FY20. Profit before tax for the quarter at ₹33.5 crores up by 342% as compared to ₹7.76 crores in Q4FY20. Company reported a very good EBITDA margin of 18.5% in Q4FY21 as compared to 12.7% in Q4FY20. Profit after tax for the quarter at ₹25 crores in Q4FY21 as compared to 5.3₹ crores up by 360% in Q4FY20. Company reported EPS for the quarter at ₹2.71 as compared to ₹0.58 in Q4FY20.

Indoco Remedies limited reported a good set of numbers, revenue growth was somewhat muted but we expect the company to do well in the upcoming quarter. On the EBITDA Margin side we have seen significant improvement in margins but we need to keep in mind that the Q4FY20 quarter was hit by the Covid Pandemic. We have a positive outlook for Indoco Remedies limited.

 

Above views are of the author and not of the website kindly read disclaimer